Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00507845
Status:
COMPLETED
Last Update Posted:
2009-04-17
First Post:
2007-07-26
Brief Title:
Use of Ramipril and Felodipine Combination Therapy in Hypertension An Effectiveness Study With Local Patients in Argentina
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Use of Ramipril and Felodipine Combination Therapy in Hypertension An Effectiveness Study With Local Patients in Argentina
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RAFEHELP
Brief Summary:
Primary
To assess effectiveness of Ramipril-Felodipine in hypertensive Argentinean patients
Secondary
To assess tolerability of Ramipril-Felodipine in hypertensive Argentinean patients
To assess effectiveness of Ramipril-Felodipine in hypertensive Argentinean patients
Secondary
To assess tolerability of Ramipril-Felodipine in hypertensive Argentinean patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None